ANITA GROESCHKE: Open Payments
NPI 1881675049 · OLMSTED FALLS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,723 in 17 payments from 12 companies in 2025. Trend: 2023 $1,135 · 2024 $963 · 2025 $1,723
Food & beverage: $1,723
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $376 |
| Madrigal Pharmaceuticals | 1 | $148 |
| Medtronic, Inc. | 1 | $147 |
| Neurocrine BioSciences, Inc. | 1 | $130 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
Products named: DUPIXENT, REZDIFFRA, SYMPLICITY G3, INGREZZA, AMVUTTRA, VYVGART, COBENFY, Symbravo.
Industry payments across OH — which companies pay providers there.
